Heparin anticoagulation responsiveness in a coronary care unit: A prospective observational study

Cardiovascular Therapeutics

Volumn 27, Issue 2, 2009, Pages 77-82

  Alsayegh, Faisal ^a   Al Rasheed, Mona ^b   Al Muhaini, Ali ^b   Al Humoud, Ekhlas ^b   Al Ostaz, Mona ^c   Mousa, Shaker A ^d  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

^c FARWANIYA HOSPITAL   (Kuwait)

^d ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Anticoagulant; Coronary care; Heparin resistance; Monitoring; Myocardial infarction; Unstable angina

Indexed keywords

HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; DEEP VEIN THROMBOSIS; DRUG RESPONSE; DRUG WITHDRAWAL; EMBOLISM; EPISTAXIS; FEMALE; GINGIVA BLEEDING; HEART FAILURE; HEMATOMA; HEMATURIA; HEMOPTYSIS; HEPARINIZATION; HUMAN; INJECTION SITE BLEEDING; KUWAIT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN BLEEDING; STROKE; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; CARDIOVASCULAR DISEASES; CORONARY CARE UNITS; DRUG MONITORING; DRUG RESISTANCE; FEMALE; HEMORRHAGE; HEPARIN; HUMANS; KUWAIT; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 65549162757     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2009.00076.x     Document Type: Article

References (20)

1. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, De Feyter PJ, Specchia G, Ruzyllo W (Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology). Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002 23 : 1809 1840.
2. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 (3 Suppl 401S 428S. (Pubitemid 39297960)
3. Hirsh J, Anand SS, Halperin JL, Fuster V. Guide to anticoagulant therapy: heparin: A statement for healthcare professionals from the American Heart Association. Circulation 2001 103 : 2994 3018. (Pubitemid 32578141)
4. Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: Diagnostic and therapeutic implications. Blood 2006 107 : 2346 2353. (Pubitemid 43345554)
5. Young E, Prins M, Levine MN, Hirsh J. Heparin binding to plasma proteins, an important mechanism for heparin resistance. Thromb Haemost 1992 67 : 639 643.
6. Warkentin TE, Hayward CP, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994 84 : 3691 3699. (Pubitemid 24979769)
7. Chew DP, Allan RM, Aroney CN, Sheerin NJ. National data elements for the clinical management of acute coronary syndromes. Med J Aust 2005 182 (9 Suppl S1 S16. (Pubitemid 40667802)
8. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 36 : 959 969.
9. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004 110 : e82 292. (Pubitemid 39036178)
10. Eikelboom J, Guyatt G, Hirsh J. Guidelines for anticoagulant use in acute coronary syndromes. Lancet 2008 371 : 1559 1561.
11. Wheeler AP, Jaquiss RD, Newman JH. Physician practices in the treatment of pulmonary embolism and deep-venous thrombosis. Arch Intern Med 1988 148 : 1321 1325. (Pubitemid 18155079)
12. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy: The emerging theme of delayed recurrence. Arch Intern Med 1997 157 : 2317 2321. (Pubitemid 27479330)
13. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med 1997 157 : 2562 2568. (Pubitemid 27519975)
14. Prandoni P, Carnovali M, Marchiori A (Galilei Investigators). Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Arch Intern Med 2004 164 : 1077 1083. (Pubitemid 38668986)
15. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 (3 Suppl 311S 337S. (Pubitemid 39297959)
16. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard monogram for the management of heparin therapy. Arch Intern Med 1991 151 : 333 337.
17. Hull RD, Raskob GE, Rosenbloom D, Lemaire J, Pineo GF, Baylis B, Ginsberg JS, Panju AA, Brill-Edwards P, Brant R. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992 Aug 152 : 1589 1595.
18. Robert RA, Brendan RM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing monogram compared with a "standard care" monogram. Ann Intern Med 1993 119 : 874 881. (Pubitemid 23316870)
19. Bernardi E, Piccioli A, Oliboni G, Zuin R, Girolami A, Prandoni P. Monograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism: An overview. Thromb Haemost 2000 84 : 22 26. (Pubitemid 30433662)
20. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 (3 Suppl 188S 203S. (Pubitemid 39297954)